Thalamic projection fiber integrity in de novo Parkinson Disease

American Journal of Neuroradiology

Volumn 34, Issue 1, 2013, Pages 74-79

  Planetta, P J ^a   Schulze, E T ^c   Geary, E K ^c   Corcos, D M ^c,d,e   Goldman, J G ^e   Little, D M ^f,g   Vaillancourt, D E ^a,b  

^a UNIVERSITY OF FLORIDA   (United States)

^b J Crayton Pruitt Family Department of Biomedical Engineering   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d University of Illinois at Chicago   (United States)

^e RUSH UNIVERSITY MEDICAL CENTER   (United States)

^f DEPARTMENT OF VETERANS AFFAIRS   (United States)

^g TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; FEMALE; FRACTIONAL ANISOTROPY; HUMAN; MALE; NERVE PROJECTION; PARKINSON DISEASE; PULVINAR; SUBSTANTIA NIGRA; THALAMUS; THALAMUS ANTERIOR NUCLEUS; THALAMUS DORSOMEDIAL NUCLEUS; THALAMUS POSTERIOR NUCLEUS; THALAMUS VENTRAL NUCLEUS; VENTRAL POSTERIOR LATERAL NUCLEUS; VENTRAL POSTERIOR MEDIAL NUCLEUS;

DIFFUSION TENSOR IMAGING; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE FIBERS, MYELINATED; PARKINSON DISEASE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; THALAMUS;

EID: 84873650731     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A3178     Document Type: Article

References (51)

1. Braak H, Del Tredici K, Rüb U, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24: 197-211
2. Hodaie M, Neimat JS, Lozano AM. The dopaminergic nigrostriatal system and Parkinson's disease: molecular events in development, disease, and cell death, andnewtherapeutic strategies. Neurosurgery 2007;60:17-28
3. Blumenfeld H. Neuroanatomy through Clinical Cases. Sunderland, Massachusetts: Sinauer Associates; 2002
4. Owen AM, Doyon J, Dagher A, et al. Abnormal basal ganglia outflow in Parkinson's disease identified with PET. Implications for higher cortical functions. Brain 1998;121:949-65
5. Braak H, Braak E. Pathoanatomy of Parkinson's disease. J Neurol 2000;247:3-10
6. Emre M. What causes mental dysfunction in Parkinson's disease? Mov Disord 2003;18:S63-71
7. Nobili F, Campus C, Arnaldi D, et al. Cognitive-nigrostriatal relationships in de novo, drug-naïve Parkinson's disease patients: a [I-123]FP-CIT SPECT Study. Mov Disord 2010;25:35-43
8. McKeown MJ, Uthama A, Abugharbieh R, et al. Shape (but not vol-ume) changes in the thalami in Parkinson disease. BMC Neurol 2008;8:8
9. Prodoehl J, Spraker M, Corcos D, et al. Blood oxygenation leveldependent activation in basal ganglia nuclei relates to specific symptoms in de novo Parkinson's disease. Mov Disord 2010;25: 2035-43
10. Halliday GM. Thalamic changes in Parkinson's disease. Parkinsonism & Relat Disord 2009;15:S152
11. Rüb U, Del Tredici K, Schultz C, et al. Parkinson's disease: the thalamic components of the limbic loop are severely impaired by asynuclein immunopositive inclusion body pathology. Neurobiol Aging 2002;23:245-54
12. Planetta PJ, Prodoehl J, Corcos DM, et al. Use of MRI to monitor Parkinson's disease. Neurodegener Dis Manag 2011;1:67-77
13. Mahlknecht P, Hotter A, Hussl A, et al. Significance of MRI in diagnosis and differential diagnosis of Parkinson's disease. Neurodegener Dis 2010;7:300-18
14. Vaillancourt D, Spraker M, Prodoehl J, et al. High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology 2009;72:1378-84
15. Péran P, Cherubini A, Assogna F, et al. Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature. Brain 2010; 133:3423-33
16. Zhan W, Kang GA, Glass GA, et al. Regional alterations of brain microstructure in Parkinson's disease using diffusion tensor imaging. Mov Disord 2012;27:90-97
17. Du G, Lewis MM, Styner M, et al. Combined r2&z.ast; and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease. Mov Disord 2011;26:1627-32
18. Basser PJ, Mattiello J, Lebihan D. MR diffusion tensor spectroscopy and imaging. Biophys J 1994;66:259-67
19. Minati L, Banasik T, Brzezinski J, et al. Elevating tensor rank increases anisotropy in brain areas associated with intra-voxel orientational heterogeneity (IVOH): a generalised DTI (GDTI) study. NMR Biomed 2008;21:2-14
20. Boska MD, Hasan KM, Kibuule D, et al. Quantitative diffusion tensor imaging detects dopaminergic neuronal degeneration in a murine model of Parkinson's disease. Neurobiol Dis 2007;26:590-96
21. Brooks D, Halliday GM. Intralaminar nuclei of the thalamus in Lewy body diseases. Brain Res Bull 2009;78:97-104
22. Henderson JM, Carpenter K, Cartwright H, et al. Degeneration of the centre median-parafascicular complex in Parkinson's disease. Ann Neurol 2000;47:345-52
23. Henderson JM, Carpenter K, Cartwright H, et al. Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications. Brain 2000;123: 1410-21
24. Chan LL, Rumpel H, Yap K, et al. Case control study of diffusion tensor imaging in Parkinson's disease. J Neurol Neurosurg Psychiatry 2007;78:1383-86
25. Li W, Liu J, Skidmore F, et al. White matter microstructure changes in the thalamus in Parkinson disease with depression: a diffusion tensor MR imaging study. AJNR Am J Neuroradiol 2010;31:1861-66
26. Little DM, Kraus MF, Joseph J, et al. Thalamic integrity underlies executive dysfunction in traumatic brain injury. Neurology 2010;74: 558-64
27. Hughes A, Daniel S, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-84
28. Hughes AJ, Ben-Shlomo Y, Daniel SE, et al. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. 1992. Neurology 2001;57:S34-38
29. Zhou X, Naier J, Reynolds H. Method to reduce eddy current effects in diffusion-weighted echo planar imaging. United States Patent, 5 1999;864:233
30. Jiang H, van Zijl PC, Kim J, et al. DTIStudio: resource program for diffusion tensor computation and fiber bundle tracking. Comput Methods Programs Biomed 2006;81:106-16
31. Cox RW. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res 1996; 29:162-73
32. DeBoy CA, Zhang J, Dike S, et al. High resolution diffusion tensor imaging of axonal damage in focal inflammatory and demyelinating lesions in rat spinal cord. Brain 2007;130:2199-210
33. Budde MD, Janes L, Gold E, et al. The contribution of gliosis to diffusion tensor anisotropy and tractography following traumatic brain injury: validation in the rat using Fourier analysis of stained tissue sections. Brain 2011;134:2248-60
34. Wimberger DM, Roberts TP, Barkovich AJ, et al. Identification of "premyelination" by diffusion-weighted MRI. J Comput Assist Tomogr 1995;19:28-33
35. Klingberg T, Vaidya CJ, Gabrieli JD, et al. Myelination and organization of the frontal white matter in children: a diffusion tensor MRI study. Neuroreport 1999;10:2817-21
36. Zhang D, Snyder AZ, Shimony JS, et al. Noninvasive functional and structural connectivity mapping of the human thalamocortical system. Cereb Cortex 2010;20:1187-94
37. Metzger CD, Eckert U, Steiner J, et al. High field FMRI reveals thalamocortical integration of segregated cognitive and emotional processing in mediodorsal and intralaminar thalamic nuclei. Front Neuroanat 2010;4:138
38. Schmahmann JD. Vascular syndromes of the thalamus. Stroke 2003; 34:2264-78
39. Klein JC, Rushworth MF, Behrens TE, et al. Topography of connections between human prefrontal cortex and mediodorsal thalamus studied with diffusion tractography. Neuroimage 2010;51:555-64
40. Behrens TE, Johansen-Berg H, Woolrich MW, et al. Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging. Nat Neurosci 2003;6:750-57
41. Jahanshahi M, Jenkins IH, Brown RG, et al. Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects. Brain 1995;118:913-33
42. Spraker M, Prodoehl J, Corcos D, et al. Basal ganglia hypoactivity during grip force in drug naïve Parkinson's disease. Hum Brain Mapp 2010;31:1928-41
43. Carrera E, Bogousslavsky J. The thalamus and behavior: effects of anatomically distinct strokes. Neurology 2006;66:1817-23
44. Yoshikawa K, Nakata Y, Yamada K, et al. Early pathological changes in the parkinsonian brain demonstrated by diffusion tensor MRI. J Neurol Neurosurg Psychiatry 2004;75:481-84
45. Gattellaro G, Minati L, Grisoli M, et al. White matter involvement in idiopathic Parkinson disease: a diffusion tensor imaging study. AJNR Am J Neuroradiol 2009;30:1222-26
46. Chaudhuri KR, Healy DG, Schapira AH, et al. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 2006;5:235-45
47. Kwon HG, Hong JH, Hong CP, et al. Dentatorubrothalamic tract in human brain: diffusion tensor tractography study. Neuroradiology 2011;53:787-91
48. Nicoletti G, Manners D, Novellino F, et al. Diffusion tensor MRI changes in cerebellar structures of patients with familial essential tremor. Neurology 2010;74:988-94
49. Leh SE, Chakravarty MM, Ptito A. The connectivity of the human pulvinar: a diffusion tensor imaging tractography study. Int J Biomed Imaging 2008:78953
50. Arend I, Machado L, Ward R, et al. The role of the human pulvinar in visual attention and action: evidence from temporal-order judgment, saccade decision, and antisaccade tasks. Prog Brain Res 2008; 171:475-83
51. Van der Werf YD, Witter MP, Groenewegen HJ. The intralaminar and midline nuclei of the thalamus. Anatomical and functional evidence for participation in processes of arousal and awareness. Brain Res Brain Res Rev 2002;39:107-40